Zobrazeno 1 - 10
of 74
pro vyhledávání: '"13-valent pneumococcal vaccine"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 1, Pp 161-168 (2020)
The CDC Advisory Committee on Immunization Practices (ACIP) recommended immunization with the recently licensed 13-valent pneumococcal conjugate vaccine (PCV13) for high-risk (immunocompromised) adults aged ≥19 years in 2012. This was in addition t
Externí odkaz:
https://doaj.org/article/3c5d5a2ac2bc4d8f8a172e75dc1a1b9b
Autor:
Germaine Hanquet, Pavla Krizova, Tina Dalby, Shamez N. Ladhani, J. Pekka Nuorti, Kostas Danis, Jolita Mereckiene, Mirjam J. Knol, Brita A. Winje, Pilar Ciruela, Sara de Miguel, Maria Eugenia Portillo, Laura MacDonald, Eva Morfeldt, Jana Kozakova, Palle Valentiner-Branth, Norman K. Fry, Hanna Rinta-Kokko, Emmanuelle Varon, Mary Corcoran, Arie van der Ende, Didrik F. Vestrheim, Carmen Munoz-Almagro, Juan-Carlos Sanz, Jesus Castilla, Andrew Smith, Birgitta Henriques-Normark, Edoardo Colzani, Lucia Pastore-Celentano, Camelia Savulescu
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 1, Pp 137-138 (2022)
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) vaccines in 10 countries in Europe. IPD incidence declined during 2011–2014 but in
Externí odkaz:
https://doaj.org/article/1f129c2eb667436c9c125a71a66c2441
Autor:
Ikuse, T., Habuka, R., Wakamatsu, Y., Nakajima, T., Saitoh, N., Yoshida, H., Chang, B., Morita, M., Ohnishi, M., Oishi, K., Saitoh, A.
Publikováno v:
Epidemiology and Infection, 2018 Oct 01. 146(14), 1793-1796.
Externí odkaz:
https://www.jstor.org/stable/26579426
Autor:
Assaf Rokney, Shalom Ben-Shimol, Zinaida Korenman, Nurith Porat, Zeev Gorodnitzky, Noga Givon-Lavi, Merav Ron, Vered Agmon, Ron Dagan, Lea Valinsky
Publikováno v:
Emerging Infectious Diseases, Vol 24, Iss 3, Pp 453-461 (2018)
Israel implemented use of 7- and 13-valent pneumococcal vaccine in 2009 and 2010, respectively. We describe results of prospective, population-based, nationwide active surveillance of Streptococcus pneumoniae serotype 12F (Sp12F) invasive pneumococca
Externí odkaz:
https://doaj.org/article/3aefd16e3ba741e7a1f0dbf1deeca866
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Camelia Savulescu, Pavla Krizova, Palle Valentiner-Branth, Shamez Ladhani, Hanna Rinta-Kokko, Corinne Levy, Jolita Mereckiene, Mirjam Knol, Brita A. Winje, Pilar Ciruela, Sara de Miguel, Marcela Guevara, Laura MacDonald, Jana Kozakova, Hans-Christian Slotved, Norman K. Fry, J. Pekka Nuorti, Kostas Danis, Mary Corcoran, Arie van der Ende, Didrik F. Vestrheim, Carmen Munoz-Almagro, Juan-Carlos Sanz, Jesus Castilla, Andrew Smith, Edoardo Colzani, Lucia Pastore Celentano, Germaine Hanquet
Publikováno v:
Vaccine
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Vaccine, 40(29), 3963-3974. Elsevier BV
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Vaccine, 40(29), 3963-3974. Elsevier BV
Background: Pneumococcal conjugate vaccines covering 10 (PCV10) and 13 (PCV13) serotypes have been introduced in the infant immunization schedule of most European countries in 2010-11. To provide additional real-life data, we measured the effectivene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf7370d11347f8a97059bcb74e97532
http://hdl.handle.net/10029/626003
http://hdl.handle.net/10029/626003
Publikováno v:
Korean Journal of Pediatrics, Vol 57, Iss 2, Pp 55-66 (2014)
The 7-valent pneumococcal protein conjugate vaccine (PCV7) has been shown to be highly efficacious against invasive pneumococcal diseases and effective against pneumonia and in reducing otitis media. The introduction of PCV7 has resulted in major cha
Externí odkaz:
https://doaj.org/article/5285126caeda4634baec10498d339e6b